Companies
/
Opentrons
Hardware
Opentrons is a Brooklyn-based life sciences company building affordable, programmable laboratory robots that automate liquid handling and other repetitive tasks for biology and biotech research labs.
$903M
+$1.81
690.13%
30 days ago
$0.26
Create an account to view live offerings, pricing, and market activity.
Sign in to view offerings and live market activity.
Sign up with Augment to see the latest market activity.
Opentrons was founded in 2014 by Will Canine, Jack Chen, and Dave Rauch, based on the observation that many essential laboratory tasks in biology and biotechnology research, particularly liquid handling, meaning the precise transfer and mixing of small liquid volumes required for countless experimental protocols, are traditionally either performed manually by researchers, a time-consuming and error-prone process, or automated using laboratory robotics systems that have historically been very expensive, often costing hundreds of thousands of dollars, putting automated liquid handling out of reach for many smaller academic labs, biotech startups, and other resource-constrained research settings. Opentrons built its laboratory automation robots using more accessible, lower-cost manufacturing approaches and an open, programmable software platform, aiming to make automated liquid handling robotics available at a small fraction of the cost of traditional laboratory automation systems, letting a much broader range of research labs, including smaller academic labs and early-stage biotech startups without large capital budgets, access automation capabilities that had previously been financially out of reach and available primarily to only the largest, most well-funded research organizations and pharmaceutical companies. The company's robots are designed to be programmed and customized using accessible software, including a Python-based programming interface, letting researchers write custom automation protocols for their specific experimental needs rather than being limited to only pre-programmed, standardized automation routines, an important flexibility given how varied and specialized biological research protocols can be across different labs and research areas. Opentrons has built a significant open-source community and library of shared automation protocols that researchers using its robots can access and adapt for their own experiments, reducing the effort required to get started with laboratory automation for common research tasks. The company's customers span academic research labs, biotech and pharmaceutical companies, and other life sciences research organizations seeking more affordable access to laboratory automation. Opentrons has raised substantial venture funding from investors including Khosla Ventures and Y Combinator, reaching unicorn status.
FOR QUALIFIED INSTITUTIONAL AND ACCREDITED INVESTORS ONLY: Under federal securities laws, private market investments on this platform are available exclusively to Institutional and Accredited Investors. Verification of status required before investing. Private investments involve significant risks including illiquidity, potential loss of principal, and limited disclosure requirements. "Augment" refers to Augment Markets, Inc. and its affiliates. Augment Markets, Inc. is a technology company offering software and data services, not a bank or financial institution. Cash Accounts are provided by Modern Treasury Corp. financial institution partners and through Augment's technology. Augment does not act as a money services business, provide money transmission, or serve as a custodian of funds. Funds held in your Cash Account are not FDIC insured unless expressly disclosed. Full terms available in the Augment Cash Account Agreement. Brokerage services are offered through Augment Capital, LLC, an affiliated broker-dealer and member FINRA/SIPC. "Investment accounts" are not brokerage accounts and do not hold customer funds or securities. Investment advisory services are offered through Augment Advisors, LLC, an SEC-registered investment adviser. Registration with the SEC does not imply a certain level of skill or training. Neither Augment Advisors, LLC nor Augment Capital, LLC provide legal or tax advice; consult your attorney or tax professional regarding your specific situation. For additional information, please refer to Augment Advisors, LLC's Form ADV Part 2A (Firm Brochure) and FINRA BrokerCheck.
